fbpx

Blog

Vaccine certainty protects Queenslanders

2 November 2023

 

Queensland Health Minister Shannon Fentiman MP has today announced that the Queensland Government will invest $40 million to ensure every Queenslander will have access free influenza vaccinations in 2024.

Under the National Immunisation Program (NIP) children aged six months to five years, pregnant women, people aged 65 and over, First Nations people and those with certain medical conditions can access no-cost vaccinations, while Australians outside of these groups pay a private fee to receive an influenza vaccination.

PSA Queensland President Shane MacDonald MPS welcomed the announcement.

“Removing cost barriers and giving Queenslanders greater access to vaccines is a great first step to improving vaccine uptake,” Mr MacDonald said.

“Queensland still falls behind national influenza coverage in almost every age group, an ongoing challenge that needs action from the whole health system, including government and all healthcare professionals.

“This is a common-sense approach to improving vaccination coverage.

“Funding certainty ahead of the 2024 flu season will mean that pharmacists can adequately prepare and meet increased demand.

“Knowing that every patient will have access to a vaccination at no cost, pharmacists can start having conversations now to encourage our patients to get their vaccine before the start of flu season.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Queensland leading nation on pharmacist vaccination scope

30 October 2023

 

Queensland is continuing to lead the nation on vaccination policy, with Health Minister the Hon. Shannon Fentiman MP today announcing expanded vaccination scope for Queensland pharmacists from 30 October 2023.

The new Extended Practice Authority (EPA) will allow pharmacists to vaccinate Queenslanders aged 2 years and older and will also authorise pharmacists to deliver vaccinations in more settings, including general practices, Aboriginal or Torres Strait Islander health services, and aged care facilities.

The new EPA will also enable pharmacists to deliver a wider range of vaccines including:

  • Hepatitis B
  • Varicella (chickenpox)
  • Meningococcal B
  • Human papillomavirus (HPV)
  • Typhoid fever
  • Zoster (herpes zoster), and
  • Japanese encephalitis.

Pharmaceutical Society of Australia (PSA) Queensland President Shane MacDonald MPS welcomed the move and the Queensland Government’s ongoing commitment to improving access to health services.

“Allowing more people to be vaccinated by their local pharmacist is a vital step in not only protecting individual Queenslanders but the entire community,” Mr MacDonald said.

“PSA has strongly advocated for pharmacists across all health settings to be able to deliver more vaccines to patients of all ages. This is a great step toward pharmacists practising to our full potential to support the health of our communities.

“On behalf of pharmacists I thank Minister Fentiman for her commitment to improving health care and ensuring that vaccinations are accessible to all Queenslanders.

“PSA also supports the authorisation of pharmacists to administer prescribed medicines in the new EPA. This is a common sense, consumer centric approach which will support patients experiencing issues with administering their own medications or accessing a health professional to administer.

“I look forward to continuing to work with the Minister and the Queensland Government to promote these new services to the community and to continue to ensure that pharmacists can practise to our top of scope and best support the health of our state,” Mr MacDonald concluded.

PSA National President Dr Fei Sim FPS said it was vital for regulations around vaccination to be consistent across all states and territories.

“At the moment, every jurisdiction in Australia has different regulations around which vaccinations can be administered by pharmacists.

“Australians should be able to access the same level of health care regardless of where they live. A nationally consistent schedule of pharmacist-administered vaccinations is key to achieve equitable access to government-funded vaccines by all Australians.

“Our health system needs all trained immunisers to play a role in delivering vaccines. We need qualified pharmacists to be able to administer vaccines wherever there is a patient need.

“I urge all states and territories to follow Queensland’s lead and allow all pharmacist immunisers, regardless of practice setting, to administer more vaccines to more Australians.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists applaud NSW red-tape cut and vaccine expansion

27 October 2023

 

The Pharmaceutical Society of Australia (PSA) welcomes the New South Wales Government’s move to expand vaccination access, with updates to the NSW Pharmacist Vaccination Standards expanding access to National Immunisation Program (NIP) vaccines, lowering minimum age requirements for Shingrix vaccines and removing written consent requirement for COVID-19 vaccines.

 

PSA New South Wales President Luke Kelly FPS said the changes cut unnecessary red tape, making vaccines more accessible across the state.

 

“As a state our focus should be on removing barriers to vaccination, cutting the red tape that prevents qualified pharmacist immunisers from delivering more vaccines to more people,” Mr Kelly said.

 

“I am proud to see years of PSA’s advocacy led to real outcomes not only for the pharmacists who will be able to play a greater role in delivering vaccines, but for our communities who will be able to access eligible vaccines closer to home.

 

“I thank the NSW Government for moving to expand NIP access for our most vulnerable populations and look forward to continuing to work alongside them to improve vaccine uptake across New South Wales.”

 

Summary of vaccination changes in NSW:

  • Lowering of the age range that pharmacist immunisers can administer Shingrix vaccine to 18 years and over (was previously 50 years and over) to align with the eligibility for Shingrix vaccine under the NIP.
  • Inclusion of monovalent meningococcal C vaccine for people aged 5 years and over to ensure pharmacist immunisers can provide a full range of meningococcal vaccines to eligible cohorts.
  • Removal of reference to COVID-19 vaccine following the recent inclusion of COVID-19 vaccine in the Australian Immunisation Handbook to be consistent with the approach for all other vaccines that pharmacist immunisers are authorised to immunise.
  • Removal of the COVID-19 vaccine written consent requirements to be consistent with consent requirements for all other vaccines i.e., that informed consent must be obtained, and documented evidence of verbal consent must be made.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Vale Valerie Constable FPS

25 October 2023

 

The Pharmaceutical Society of Australia (PSA) has honoured Ms Valerie Constable FPS, the first female President of PSA’s Victorian branch, who sadly passed away recently.

For more than three decades, Valerie (Val) Constable has helped pave the way to optimise standards of pharmacy education and practice, becoming a trusted mentor to many.

A humble and highly regarded professional, Val was a leader for women in pharmacy. She was a preceptor, mentor, and role model to many and always made herself available to provide support and advice to any member of the profession who sought her wisdom or assistance. Val’s principles are epitomised by Pharmacists Support Services (PSS), the anonymous volunteer support service that she helped establish, and led for many years.

In 1991, Val was the first female in 135 years to be elected President of the PSA’s Victorian Branch. She rose above the glass ceiling through outstanding commitment, integrity, and professionalism. For over 35 years, Val and her husband Bob provided patient-centred care to their local communities through their pharmacies in Footscray and Pascoe Vale in Melbourne. She was a mentor to numerous trainees, many of whom have gone on to be prominent members of the profession.

Val recognised the need for greater structure in pharmacy training and worked with other pharmacists to establish the Chapter of Pharmacy Practice Tutors, and co-authored manuals on medical conditions treated through pharmacies. She was also a Board member of the National Asthma Campaign (precursor to the National Asthma Council), involved with educating pharmacists in asthma recognition and management, and development of the Asthma Management Plan.

PSA Victoria President Dr Amy Page FPS honoured Ms Constable’s impact on all Victorian pharmacists.

“Val was a trailblazer for Victorian pharmacists, forging the path for women in the profession to follow,” Dr Page said.

“Many Victorians will remember Val for her wisdom and tenacity, whether in one of her pharmacies in Footscray or Pascoe Vale, or as a leader of the profession.

“She has been a mentor to many, inspiring and supporting young pharmacists in practice.

“Her legacy will continue to inspire pharmacists for many years to come.”

PSA National President Dr Fei Sim FPS also highlighted Ms Constable’s lasting legacy.

“In 1995, with a group of similarly minded pharmacists, Val Constable set up the Pharmacists’ Support Service (PSS) to help peers experiencing stress.

“The profession is forever indebted to Val for her commitment to improving our profession, driving PSS in its early years.

“Val was a leader who led by compassion and had touched many hearts through her genuine support for colleagues and community.

“On behalf of all pharmacists, I offer my deepest condolences to the Constable family, their friends and colleagues,” Dr Sim concluded.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists to better support patients with insomnia and sleep health

25 October 2023

 

Pharmacists will soon have access to nation-leading sleep health education and resources to support patients experiencing insomnia. PSA will work as part of a consortium led by the Australasian Sleep Association, to deliver the Quality Use of Medicines for Insomnia and Sleep Health (QUMISH) project.

The grant will run over a 2-year period and address quality use of medicines issues for insomnia, awarded under the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program.

The Pharmaceutical Society of Australia (PSA) National President Dr Fei Sim FPS said the funding supports quality use of medicines as a national health priority.

“Every day pharmacists are supporting patients with their sleep health,” Dr Sim said.

“Most Australians experience insomnia at some stage in their lives, with about 1 in 10 people experiencing insomnia symptoms at any given time.

“As some of the most accessible health care professionals, pharmacists are ideally placed to identify patients with insomnia who need further support.

“Through education and resources developed with the Australasian Sleep Association and other stakeholders, pharmacists will have confidence in providing high-quality, consistent care for Australians experiencing insomnia.

“PSA is proud to take a collaborative approach to upskilling pharmacists with evidence-based training on the quality use of medicines for insomnia, as well as other first line strategies for improving sleep health.

“Pharmacists will have access to webinars, CPD articles and in-person education at PSA’s Pharmacist Therapeutic Updates and national conference.

“I strongly encourage all pharmacists to engage with this education and recognise that opportunistic interventions by community pharmacists are key to improving sleep health for all Australians,” Dr Sim concluded.

PSA is delivering education in consortium with the Australasian Sleep Association, the Sleep Health Foundation and the University of Sydney.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA prepares pharmacists for Victorian scope expansion

24 October 2023

 

The Pharmaceutical Society of Australia (PSA) has launched its education series to prepare pharmacists participating in the Victorian Community Pharmacist Statewide Pilot.

The 12-month pilot is aimed at testing an expanded role for community pharmacists, authorising the continued supply of oral contraceptive pills without a prescription, as well as supply of antibiotics for uncomplicated urinary tract infections.

It is a requirement that pharmacists complete appropriate training, including PSA’s Contraception essentials and Managing uncomplicated cystitis (Urinary Tract Infection)  programs.

Both modules are available to all Victorian pharmacists, and are free for PSA members.

PSA Victoria President Dr Amy Page FPS urges pharmacists to complete training as soon as possible.

“PSA is proud to build on our existing support for pharmacists to maximise opportunities to develop their practice and deliver high quality care to patients as pharmacist scope continues to evolve,” Dr Page said.

“This is an exciting opportunity for community pharmacists to not only expand their scope, but also to provide accessible care for all Victorians, particularly those in rural and regional parts of our state.

“These programs empower pharmacists with the knowledge and skills required to make a meaningful difference in the lives of Victorians while contributing to the success of the Victorian Community Pharmacist Statewide Pilot.

“This is about making sure that Victorians have access to safe health care when and where they need it,” Dr Page concluded.

Enrolments are now open for the Contraception essentials and Managing uncomplicated cystitis (Urinary Tract Infection)  training modules.

For more information on the Victorian Community Pharmacist Statewide Pilot, visit the Department of Health website.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Launch of new PPS Quality Improvement and Self-Assessment Implementation Program

14 October 2023

 

The Pharmaceutical Society of Australia (PSA) has today officially launched the Professional Practice Standards Quality Improvement and Self-Assessment Implementation Program to help pharmacists better understand and implement the standards into their practice.

 

The Implementation Program enables pharmacists to identify their individual scope of practice and the Standards relevant to them, as well as self-assess against these.
Upon completing the program, pharmacists are provided with a tailored action plan to help them improve their practice.

 

Speaking at the Western Australia Annual Therapeutic Update in Perth, PSA National President Dr Fei Sim FPS strongly encouraged pharmacists to take advantage of the Quality Improvement and Implementation Program to improve their practice.

 

“When we launched the new Professional Practice Standards earlier this year, we knew that it would fundamentally change the way pharmacists interact with and apply professional standards to their own practice,” Dr Sim said.

 

“Our Implementation Program allows each pharmacist to take an individual approach to applying the Standards in practice, no matter what our area of practice or specialisation.
“Self-assessing performance against these standards allows all of us to better our practice, and to deliver better care to all Australians.

 

“As pharmacists’ scope of practice continues to evolve, it is vital we continually assess our own performance and whether we are consistently enabling the delivery of safe, high-quality, reliable, and clinically effective healthcare services.

 

“I encourage all pharmacists, in all areas of practice and in all career stages to make the most of the Professional Practice Standards Quality Improvement and Self-assessment Implementation Program as a contemporary, evidence-based resource to guide their quality professional practice.

 

“By incorporating these standards into daily practice, pharmacists will ensure safe, effective and person-centred care for all Australians,” Dr Sim concluded.

 

The launch of this interactive program reaffirms PSA’s dedication to supporting pharmacists to provide top-quality healthcare services to the community. PSA remains committed to equipping pharmacists with the knowledge and tools they need to excel in their roles and improve patient outcomes.

 

The Professional Practice Standards, the implementation program, and more are available at https://www.psa.org.au/practice-support-industry/pps/

 

 

Media contact: Georgia Clarke M: 0480 099 798 E: georgia.clarke@psa.org.au

Consultation begins for palliative care foundation training program

13 October 2023

 

The Pharmaceutical Society of Australia (PSA) has opened consultation for the development of the National Palliative Care Foundation Training Program announced earlier this year.

PSA is seeking input from pharmacists and other key stakeholders to help inform the learning objectives and content for this training program.

PSA National President Dr Fei Sim FPS encouraged all pharmacists to submit their feedback.

“This foundation training program is about upskilling the most easily accessible health professional to support palliative care,” Dr Sim said.

“Upskilling pharmacists in palliative care will increase the capacity of palliative care teams to support people who have been diagnosed with a life limiting illness.

“I strongly encourage pharmacists, whether experienced or interested in palliative care or not, to share their views to help us create a training program that best serves the needs of patients, their families and palliative care multidisciplinary teams.”

Consultation for the National Palliative Care Foundation Training for Pharmacists closes on 17 November 2023.

To contribute your views, please visit https://forms.office.com/r/UfW50J4LHX

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Next generation of early career pharmacy leaders announced

12 October 2023

 

The Pharmaceutical Society of Australia (PSA) has appointed ten early career pharmacists from around Australia to lead the ECP Community of Specialty Interest (CSI), and support ECP Board Director Ayomide Ogundipe MPS as CSI Chair.

The ECP Community of Specialty Interest will be led by:

  • Ayomide Ogundipe MPS (Chair)
  • Abby Richardson MPS
  • Elissar Mansour MPS
  • Erin Cooper MPS
  • Jala Moushi MPS
  • James Buckley MPS
  • Keiran Batavia MPS
  • Monique Licht MPS
  • Raymond Truong MPS
  • Shaylee Mills MPS

 

ECP Board Director and Community of Specialty Interest Chair Ayomide Ogundipe MPS celebrated the diverse range of skills and experience each leader brings to the team.

“Working closely with the CSI leadership team, we are continuing to build and foster peer support through mentoring, engagement with ECPs across all states and territories and policy and advocacy,” Ms Ogundipe said.

“Our profession is seeing a paradigm shift in practice and scope, and it is so important that ECPs are part of these discussions moving forward to bring their diverse insights and experiences to the table.

“Through the CSI Early Career Pharmacists have a direct avenue to actively engage with PSA and the broader profession. I encourage all pharmacists in the early stages of their careers to get involved and join the CSI.”

PSA Chief Executive Officer A/Prof Steve Morris also welcomed the ECP leadership team.

“The ECP Community of Specialty Interest offers pharmacists in the early stages of their careers the opportunity to connect with their colleagues and shape the direction of our profession,” A/Prof Morris said.

“PSA proudly supports early career pharmacists to get the most out of their careers, from their registration to retirement.

“I am looking forward to continuing our work with Ayomide and her team to ensure that PSA is best supporting pharmacists at all stages of their careers.”

The Early Career Pharmacist – Community of Specialty Interest is an exclusive forum for PSA members. Join PSA today by visiting www.psa.org.au/membership

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSS elects next President

11 October 2023

 

The Pharmaceutical Society of Australia (PSA) has thanked outgoing Pharmacist Support Service (PSS) President John Coppock OAM FPS for his service to the profession, having led the organisation since 2010.

PSA National President Dr Fei Sim FPS acknowledged Mr Coppock’s longstanding dedication to supporting pharmacists and the broader profession.

“PSA has long supported the vital work that PSS does to ensure that pharmacists have mental health resources available when they need them and will continue to do so.

“We are immensely proud of the impact that John, CEO Kay Dunkley, and their team at PSS have had on our profession, lending a listening ear to any pharmacist, pharmacy student or intern who may need it. It is with this support that we can provide the best care to our own patients.

“On behalf of the profession I sincerely thank John for his many years of leadership and wish him well in his well-deserved retirement.”

Dr Sim also congratulated Curtis Ruhnau MPS on his election as the next PSS President, alongside Helen Dowling MPS who was re-elected as Vice President, and PSA Life Member David North OAM MPS who was re-elected as Treasurer.

“Curtis is a strong leader with a genuine understanding of the challenges our profession is facing.

“I have no doubt that the PSS will thrive under his leadership.

“I look forward to continuing our work with PSS, under Curtis’ leadership, to support pharmacists and the profession,” Dr Sim concluded.

 

The Pharmacists Support Service (PSS) is available to provide a listening ear and support over the phone every day of the year from 8am to 11pm AEDT. Call 1300 244 910 for anonymous and confidential support from a pharmacist colleague over the phone.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au